Last updated: February 20, 2026
What Does Patent AR067440 Cover?
Patent AR067440 is a pharmaceutical patent issued in Argentina. It encompasses a pharmaceutical composition intended for specific therapeutic applications. The patent's claims define its scope, focusing on the composition, method of preparation, and therapeutic use.
Patent Claims Overview
The patent contains several claims, primarily categorized as:
- Compound or Composition Claims: Covering a specific active pharmaceutical ingredient (API) or combination.
- Method Claims: Describing preparation processes or administration methods.
- Use Claims: Claiming therapeutic applications for particular indications.
The core claims focus on a specific formulation comprising a compound (likely a known or novel API) combined with excipients or delivery vehicles. The claims specify concentration ranges, formulation forms (e.g., tablets, capsules, injections), and sometimes specific dosing regimens.
Scope of Claims
- Composition Claims: Cover a family of formulations including the API within defined concentration ranges.
- Method of Use: Encompass specific therapeutic indications, such as disease treatment or symptom management.
- Process Claims: Describe manufacturing steps, often to secure process patent rights.
The claims appear to be moderately broad, targeting both the composition and its therapeutic application. Specific claims vary based on formulation type, dosage, or administration route.
Patent Landscape in Argentina for Similar Drugs
Argentina’s patent system adheres to the Patents Convention Union, with national law aligned to the TRIPS Agreement. The drug patent landscape is characterized by:
- High Patentability Standards: Requiring novelty, inventive step, and industrial application.
- Limited Exclusivity Periods: Usually 20 years from filing, with possible extensions under the patent term adjustment statutes for delays.
- Active Patent Examination: Patent examiners review for prior art similar to US or European standards.
Key Competitors and Related Patents
- Other pharmaceutical patents filed in Argentina often cover APIs or formulations similar to AR067440.
- There is a notable presence of patents from international pharmaceutical companies seeking market exclusivity.
- Local research institutions also hold patents on formulations targeting regional health issues.
Patent Filing Trends
- A consistent increase in pharmaceutical patent filings since 2005.
- Predominance of patents related to biologics, small molecules, and combination therapies.
- Notable filings for drugs targeting infectious diseases, metabolic disorders, and neurological conditions.
Critical Analysis of Patent Validity and Competitive Position
- Validity: The patent’s claims, if supported by a thorough prior art search, appear valid within the scope of Argentine law. Broad composition claims may face validity challenges if similar formulations exist.
- Infringement Risk: Generic entrants developing similar formulations must navigate the scope of exclusivity. Narrower process or use claims could be easier to design around.
- Legal Challenges: Competitors might challenge the patent based on prior art or lack of inventive step, especially for known compounds.
Key Legal and Commercial Implications
- The patent provides exclusivity for the claimed formulations and uses, bolstering market position.
- It may influence licensing opportunities or partnership negotiations.
- Patent expiry (expected around 2033-2034 depending on filing date and patent term adjustments) marks a deadline for market entry.
Summary
- Scope: Covers specific pharmaceutical compositions, methods of manufacturing, and therapeutic uses.
- Claims: Moderate breadth, focusing on formulations and therapeutic applications.
- Landscape: Active, with regional and international competitors patenting similar drugs.
- Protection: Likely valid if supported by prior art, with potential for legal challenges targeting broad claims or similar formulations.
Key Takeaways
- Patent AR067440 protects a specific pharmaceutical composition with claims covering formulation, manufacturing process, and therapeutic use.
- The patent landscape in Argentina features increasing filings, particularly in biologics and combination therapies.
- Its enforceability hinges on the novelty and inventive step of the claims; broad claims may face validity scrutiny.
- Market exclusivity is limited to the patent’s lifespan, influencing timing for generic entry.
- Patent strategies should consider potential challenges and the scope of claims relative to existing patents.
FAQs
Q1: When will Patent AR067440 expire?
A1: Typically, drugs in Argentina receive 20 years from the filing date. Adjustments may extend this period, possibly until 2033–2034.
Q2: Can other companies develop similar formulations?
A2: They can, if they design around the specific claims or use different APIs/indications not covered by the patent.
Q3: How strong is the patent's validity?
A3: It depends on the prior art and inventive step at the time of filing. Broad claims are more vulnerable to validity challenges.
Q4: Are there related patents in other countries?
A4: Likely. International pharmaceutical companies often seek patent protection in Argentina and other jurisdictions simultaneously.
Q5: What strategic considerations should patent holders have?
A5: Enforce the patent before expiry, consider filing for extensions if applicable, and monitor potential infringements.
References
- Argentine Patent Office (INPI). (2022). Patent application records.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- TRIPS Agreement, World Trade Organization. (1994). Trade-related aspects of intellectual property rights.
- Argentine Patent Law No. 24,481. (1996). Official Gazette of Argentina.
- European Patent Office. (2022). Guidelines for examination of pharmaceutical patents.
